CNN Calls Out 'Cataract Risk' in HOPE-3

— Statins and cataracts: So what?

by Peggy Peck, Editor-in-Chief, 榴莲视频 April 4, 2016

This article is a collaboration between 榴莲视频 and:

CHICAGO -- Two days after HOPE-3 results were lauded as proof of statins' safety and efficacy, CNN quotes a : "first randomized trial to show risk of cataracts w/statins." 榴莲视频 asks Deepak Bhatt, Steven Nissen, C. Michael Valentine, and Alfred Bove to put this risk into perspective.